Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
Реферат RUS | Реферат ENG | Литература | Полный текст |
УДК: | 617.735-002 DOI: https://doi.org/10.25276/2410-1257-2020-3-68-70 |
Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А.
Морфогенез ретинобластомы при локальном введении цитостатиков
1. Kaneko A, Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn. J. Clin. Oncol. 2003; 33 (12): 601-607.
2. Munier FL, Gaillard MC, Balmer A et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br. J. Ophthalmol. 2012; 96 (8): 1078-1083.
3. Ghassemi F, Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch. Ophthalmol. 2012; 130 (10): 1268-1271.
4. Francis JH, Schaiquevich P, Buitrago E et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology. 2014; 121: 1810-1817.
5. Ghassemi F, Amoli FA. Pathological findings in enucleated eyes after intravitreal melphalan injection. Int. Ophthalmol. 2014; 34: 533-540.
6. Daniels AB, Froehler MT, Nunnally AH et al. Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach. Investigative Opthalmology & Visual Science. 2019; 60 (4): 954-964.
7. Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br. J. Ophthalmol. 2014; 98 (3): 292- 297.
8. Aziz HA, Kim JW, Munier FL, Berry JL. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocular Oncology and Pathology. 2016; 3 (1): 34-40.
9. Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic Observations After Intra-arterial Chemotherapy for Retinoblastoma. Arch. Ophthalmol. 2011; 129 (11): 1416-1421.
10. Biewald EM, Bornfeld N, Metz KA et al. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br. J. Ophthalmol. 2019; 10: 1-5.
11. Vajzovic LM, Murray TG, Aziz-Sultan MA et al. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch. Ophthalmol. 2010; 128 (12): 1619-1623.
12. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008; 115 (8): 1398-1404.
2. Munier FL, Gaillard MC, Balmer A et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br. J. Ophthalmol. 2012; 96 (8): 1078-1083.
3. Ghassemi F, Shields CL. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch. Ophthalmol. 2012; 130 (10): 1268-1271.
4. Francis JH, Schaiquevich P, Buitrago E et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology. 2014; 121: 1810-1817.
5. Ghassemi F, Amoli FA. Pathological findings in enucleated eyes after intravitreal melphalan injection. Int. Ophthalmol. 2014; 34: 533-540.
6. Daniels AB, Froehler MT, Nunnally AH et al. Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach. Investigative Opthalmology & Visual Science. 2019; 60 (4): 954-964.
7. Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br. J. Ophthalmol. 2014; 98 (3): 292- 297.
8. Aziz HA, Kim JW, Munier FL, Berry JL. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocular Oncology and Pathology. 2016; 3 (1): 34-40.
9. Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic Observations After Intra-arterial Chemotherapy for Retinoblastoma. Arch. Ophthalmol. 2011; 129 (11): 1416-1421.
10. Biewald EM, Bornfeld N, Metz KA et al. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br. J. Ophthalmol. 2019; 10: 1-5.
11. Vajzovic LM, Murray TG, Aziz-Sultan MA et al. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch. Ophthalmol. 2010; 128 (12): 1619-1623.
12. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008; 115 (8): 1398-1404.
Страница источника: 68-70
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн